Global Liver Institute
News
GLOBAL LIVER INSTITUTE
The Latest at GLI: October 2022
At GLI, we know that Liver Health is Public Health – which means that prevention is perhaps our greatest tool to keep livers around the world healthy. These past few months have been busy – and they...
Global Liver Institute Recognized as a Healthy People 2030 Champion
Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating worldwide, announces that the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) has recognized the organization as a Healthy People 2030 Champion.
Rates of Liver Cancers Are Going Up – and Communities of Color Face the Most Risk
Global Liver Institute (GLI) today launches its 5th annual #OctoberIs4Liver education and awareness campaign, which calls attention to liver cancer – the third deadliest cancer in the world. Throughout the month, GLI will use media, social media, educational expert panels, and other events to…
Patient Story Feature: The Advocacy (and Research) That Saved My Life by Melinda Bachini
After brushing off the symptoms of shoulder pain, fatigue, and GI issues as part of my career as a paramedic, I eventually scheduled an appointment with my primary care physician in 2009 when I suspected that I had gallbladder stones. The ultrasound revealed that I had a grapefruit-sized tumor on my liver…
Patient Story Feature: The Ups and Downs of a Liver Cancer Journey by Anthony Villiotti
St. Patrick’s Day seems to be a recurring theme throughout my liver cancer journey: I was diagnosed with hepatocellular carcinoma on March 17, 2017 and exactly one year later, I received the phone call telling me that I was getting a new liver. Before my battle with liver cancer, I had struggled with weight problems, diabetes, NASH, and cirrhosis…
Liver Cancer Won’t Wait. We Shouldn’t Either.
“You have liver cancer.” It’s a sentence that nobody wants to hear, but far too many people have heard (likely hundreds of thousands this year). Despite the prominent position that cancer has played...
Changing A Name: More Than An Academic Exercise
People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years...
GLI Recognizes and Supports Primary Biliary Cholangitis Day
GLI Recognizes and Supports Primary Biliary Cholangitis Day Global Liver Institute (GLI) is proud to support liver patients worldwide in recognition of International Primary Biliary Cholangitis...
Global Liver Institute Congratulates Dr. Monica Bertagnolli for Imminent Appointment as Director of the National Cancer Institute
Washington, DC – August 12, 2022 – As leaders in the liver cancers community, Global Liver Institute (GLI) proudly supports President Biden’s selection of Monica Bertagnolli, MD, to be appointed as the Director of the National Cancer Institute (NCI).
Bertagnolli is the first woman to serve as chief of the Division of Surgical Oncology at Brigham and…
The Embassy of Italy Joins Global Liver Institute to commemorate International NASH Day
(Washington, DC – June 14, 2022) – The Embassy of Italy, in collaboration with Global Liver Institute (GLI), will host an event on June 14 entitled “From Progress in the Control of Viral Hepatitis to the Rising Epidemic of NASH” for the occasion of International NASH Day, a liver health awareness campaign led annually by GLI in June. The event will feature a scientific presentation highlighting the bilateral…
International NASH Day Highlights a Common – But Unfamiliar – Liver Disease
Washington, DC – June 8, 2022 – Global Liver Institute (GLI) calls attention to NASH by leading the 5th annual International NASH Day on June 9. The number of people with this advanced liver disease is expected to double by 2030, but #NASHday aims to prevent this growth. Join the movement…
The Road to #NASHday: Guidelines, Roadmaps, & Actions for Today
In 2021, GLI NASH Council partners collaborated to draft this set of actionable recommendations for the full spectrum of stakeholders involved in NASH prevention and treatment, including: patients and caregivers, clinicians, patient advocacy organizations, medical societies, industry…